Annals of Allergy Asthma & Immunology

The Annals of Allergy, Asthma & Immunology is the official journal of the American College of Allergy, Asthma & Immunology, published monthly by Elsevier, whose 2025 Journal Impact Factor is 7.1《过敏、哮喘与免疫学年鉴》（Annals of Allergy Asthma & Immunology）是美国过敏、哮喘与免疫学学会的官方期刊，由（Elsevier）按月出版，2025 年影响因子为 7.1。

Scope

• The journal publishes papers on a broad range of topics in allergy, asthma and immunology, and is written for the physician who treats allergic and immunologic disorders or asthma该刊发表过敏、哮喘与免疫学领域广泛主题的论文，读者对象为诊治变态反应性疾病、免疫性疾病与哮喘的临床医师。
• It keeps clinicians informed of the latest basic and clinical concepts as well as the pharmacology and clinical use of drugs期刊向临床医师传递最新的基础与临床概念，以及药物的药理学与临床使用要点。
• Organ-specific immunologic disease is covered, including dermatologic, gastrointestinal, respiratory and ocular disorders内容覆盖器官特异的免疫性疾病，包括皮肤、胃肠、呼吸与眼部相关疾病。
• Editorial features include continuing medical education review articles together with a variety of original scientific communications栏目设置包括继续医学教育综述文章，以及多种形式的原创科学论文。
• The journal welcomes original research as well as review and invited article types, and accepted papers appear simultaneously in print and online期刊接收原创研究，也设有综述与受邀稿件类型，录用文章同时在纸本与在线版刊出。
• Reported turnaround is less than 30 days from submission to first decision and less than 80 days from submission to acceptance据官方投稿指南，投稿至首次决定通常在 30 天以内，投稿至录用通常在 80 天以内。

History

• The journal was established in 1943 under the name Annals of Allergy and obtained its current title in 1995该刊于 1943 年以（Annals of Allergy）之名创刊，1995 年改为现名。
• It is the official journal of the American College of Allergy, Asthma & Immunology, the professional college for allergy and immunology specialists in the United States它是美国过敏、哮喘与免疫学学会的官方期刊，该学会是美国变态反应与免疫学专科医师的专业组织。
• By the 2018 volume the journal had begun its 75th year of publication, continuing a long tradition of clinical allergy publishing2018 年卷起该刊进入创刊第 75 年，延续了临床变态反应学办刊的长期传统。
• Annals is published for the college by Elsevier as a monthly title indexed in the Science Citation Index Expanded该刊由（Elsevier）代表学会按月出版，并被（Science Citation Index Expanded）收录。
• Its 2025 Journal Impact Factor rose to 7.1 from 4.7 a year earlier, moving it to 5th among 40 allergy journals and 28th among 183 immunology journals其 2025 年影响因子由前一年的 4.7 升至 7.1，在 40 种过敏学期刊中列第 5 位，在 183 种免疫学期刊中列第 28 位。

Editors

• The Editor-in-Chief is Mitchell H. Grayson, MD, of Nationwide Children's Hospital and The Ohio State University in Columbus, Ohio现任主编为（Mitchell H. Grayson），任职于（Nationwide Children's Hospital）与（The Ohio State University），工作地点在俄亥俄州哥伦布市。
• Jonathan Spergel of the Children's Hospital of Philadelphia serves as Deputy Editor, with Donald Y. M. Leung as Senior Executive Editor and John Oppenheimer as Executive Editor副主编为（Children's Hospital of Philadelphia）的（Jonathan Spergel），高级执行编辑为（Donald Y. M. Leung），执行编辑为（John Oppenheimer）。
• The editorial board has about 82 members from six countries and regions, with 74 from the United States, 3 from Italy, 2 from Canada and the rest from Australia, Israel and Singapore编委会有约 82 位成员，来自 6 个国家和地区，其中美国 74 位、意大利 3 位、加拿大 2 位，其余来自澳大利亚、以色列与新加坡。
• Manuscripts are peer reviewed and handled through the journal's web-based submission system, with decisions and revision requests communicated to authors稿件经同行评审，并通过期刊的网络投稿系统处理，编辑决定与修改要求均向作者反馈。
• Continuing medical education review articles are a characteristic feature of the journal's editorial programme继续医学教育综述文章是该刊编辑方针中的特色栏目。